Zila Biotechnology, Inc.   Report issue

For profit Phase 3
Founded: Phoenix AZ United States (1980)
Status: Acquired by Tolmar Inc. (2009)

Organization Overview

First Clinical Trial
2006
NCT00537199
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

oratest (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Oropharyngeal Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1